Japan’s No.1 in cardiovascular sales
We have the largest market share in the products for PCI (percutaneous coronary intervention), minimally invasive treatments for myocardial infarction and angina pectoris in Japan.
*(Source) WIN Partners
Financial summary.
WIN-Partners group aims for higher growth, by expanding sales network and customer base as well as expanding treatment areas and products.